Clinical Trials Directory

Trials / Completed

CompletedNCT01467349

Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan

Efficacy of Raltegravir in a Large Urban HIV Clinic Population in Milan (Efficacy of Raltegravir in a Large Urban HIV Clinic Setting)

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Università Vita-Salute San Raffaele · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This will be a retrospective analysis of efficacy, safety and tolerability of raltegravir as part of an optimized therapy in a clinical setting. Follow-up is calculated from the treatment initiation (with or without raltegravir) up to the date of discontinuation of the considered regimen or the date of last visit or the date of lost to follow-up, whichever came first. The Aim of the study is to evaluate the efficacy and safety of raltegravir-containing regimens in a urban clinic setting.

Conditions

Timeline

Start date
2011-12-01
Primary completion
2012-10-01
Completion
2012-12-01
First posted
2011-11-08
Last updated
2013-02-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01467349. Inclusion in this directory is not an endorsement.

Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan (NCT01467349) · Clinical Trials Directory